Cerity Partners’s Standard BioTools LAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $45K | Buy |
37,501
+15,470
| +70% | +$18.6K | ﹤0.01% | 2553 |
|
|
2025
Q1 | $23.8K | Buy |
+22,031
| New | +$23.8K | ﹤0.01% | 2437 |
|
|
2023
Q3 | – | Sell |
-12,588
| Closed | -$24.3K | – | 1569 |
|
|
2023
Q2 | $24.3K | Hold |
12,588
| – | – | ﹤0.01% | 1598 |
|
|
2023
Q1 | $24.5K | Hold |
12,588
| – | – | ﹤0.01% | 1818 |
|
|
2022
Q4 | $14.7K | Buy |
12,588
+182
| +1% | +$213 | ﹤0.01% | 1461 |
|
|
2022
Q3 | $13K | Buy |
12,406
+406
| +3% | +$425 | ﹤0.01% | 1168 |
|
|
2022
Q2 | $19K | Sell |
12,000
-100
| -0.8% | -$158 | ﹤0.01% | 1165 |
|
|
2022
Q1 | $43K | Sell |
12,100
-10
| -0.1% | -$36 | ﹤0.01% | 920 |
|
|
2021
Q4 | $47K | Hold |
12,110
| – | – | ﹤0.01% | 1002 |
|
|
2021
Q3 | $80K | Hold |
12,110
| – | – | ﹤0.01% | 672 |
|
|
2021
Q2 | $75K | Buy |
12,110
+10
| +0.1% | +$62 | ﹤0.01% | 700 |
|
|
2021
Q1 | $55K | Buy |
12,100
+100
| +0.8% | +$455 | ﹤0.01% | 686 |
|
|
2020
Q4 | $72K | Hold |
12,000
| – | – | ﹤0.01% | 633 |
|
|
2020
Q3 | $89K | Sell |
12,000
-11,257
| -48% | -$83.5K | ﹤0.01% | 490 |
|
|
2020
Q2 | $93K | Buy |
23,257
+2,000
| +9% | +$8K | 0.01% | 444 |
|
|
2020
Q1 | $54K | Buy |
+21,257
| New | +$54K | ﹤0.01% | 435 |
|
|
2019
Q4 | – | Sell |
-10,721
| Closed | -$50K | – | 556 |
|
|
2019
Q3 | $50K | Sell |
10,721
-10,721
| -50% | -$50K | ﹤0.01% | 470 |
|
|
2019
Q2 | $264K | Buy |
+21,442
| New | +$264K | 0.02% | 415 |
|